NetworkNewsBreaks – Healthtech Solutions Inc. (H
Post# of 26
(Total Views: 182)
Posted On: 06/14/2021 4:25:30 PM
NetworkNewsBreaks – Healthtech Solutions Inc. (HLTT) Building Unique Structure to Bring Innovative Biotech to Market
Healthtech Solutions (OTC: HLTT) was featured in a recent article regarding its strategic appointment of CEO Edward Swanson, MD, who brings a broad array of scientific, clinical and industry specific expertise. The piece also highlighted the company’s focus to adopt a unique, portfolio-style business model. HLTT’s latest acquisition of Varian Biopharmaceuticals Inc., a precision oncology company developing novel therapeutics for the treatment of cancer, will add to its growing health care portfolio. To date, in addition to Varian Biopharmaceuticals, Healthtech Solutions is also the parent company to cloud-based ultrasound technology provider, MediScan Inc., as well as RevHeart Inc., a wholly owned subsidiary focused around treating COVID-related heart muscle injury. “I am thrilled to be joining the Healthtech team to build out a unique portfolio-style business model to bring innovative biotech and medical device technologies to the market and impact patient lives,” said Dr. Swanson. “The decentralized development of assets in this structure leverages nimble operating efficiencies at the subsidiary level combined with the experience and skillsets of the management team of Healthtech.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Healthtech Solutions (OTC: HLTT) was featured in a recent article regarding its strategic appointment of CEO Edward Swanson, MD, who brings a broad array of scientific, clinical and industry specific expertise. The piece also highlighted the company’s focus to adopt a unique, portfolio-style business model. HLTT’s latest acquisition of Varian Biopharmaceuticals Inc., a precision oncology company developing novel therapeutics for the treatment of cancer, will add to its growing health care portfolio. To date, in addition to Varian Biopharmaceuticals, Healthtech Solutions is also the parent company to cloud-based ultrasound technology provider, MediScan Inc., as well as RevHeart Inc., a wholly owned subsidiary focused around treating COVID-related heart muscle injury. “I am thrilled to be joining the Healthtech team to build out a unique portfolio-style business model to bring innovative biotech and medical device technologies to the market and impact patient lives,” said Dr. Swanson. “The decentralized development of assets in this structure leverages nimble operating efficiencies at the subsidiary level combined with the experience and skillsets of the management team of Healthtech.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)